Juan A Moreno
Overview
Explore the profile of Juan A Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
726
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mas-Fontao S, Civantos E, Boukichou N, Moreno J, Tuomilehto J, Gabriel R, et al.
Sci Rep
. 2024 Dec;
14(1):30336.
PMID: 39638835
This sub-analysis of the ePREDICE trial, investigated the prevalence and determinants of renal complications, specifically glomerular hyperfiltration, albuminuria, and reduced kidney function, in individuals with prediabetes (PD). The cohort consisted...
2.
Mas-Fontao S, Tarin N, Cristobal C, Soto-Catalan M, Pello A, Acena A, et al.
Clin Investig Arterioscler
. 2024 Sep;
37(2):100735.
PMID: 39343690
Objectives: To examine the relationship between inflammatory biomarkers and the occurrence of cardiovascular events in patients with type 2 diabetes mellitus (DM2) and stable coronary artery disease. Methods: A total...
3.
Beltran-Camacho L, Bhosale S, Sanchez-Morillo D, Sanchez-Gomar I, Rojas-Torres M, Eslava-Alcon S, et al.
Int J Biol Sci
. 2023 Apr;
19(6):1664-1680.
PMID: 37063416
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection significantly affects the cardiovascular system, causing vascular damage and thromboembolic events in critical patients. Endothelial dysfunction represents one of the first steps...
4.
Calderon-Dominguez M, Trejo-Gutierrez E, Gonzalez-Rovira A, Beltran-Camacho L, Rojas-Torres M, Eslava-Alcon S, et al.
Mol Ther Nucleic Acids
. 2022 Jun;
29:76-87.
PMID: 35721225
Despite the extraordinary advances achieved to beat COVID-19 disease, many questions remain unsolved, including the mechanisms of action of SARS-CoV-2 and which factors determine why individuals respond so differently to...
5.
Martin-Sanchez D, Fontecha-Barriuso M, Martinez-Moreno J, Ramos A, Sanchez-Nino M, Guerrero-Hue M, et al.
Nefrologia (Engl Ed)
. 2020 Jul;
40(4):384-394.
PMID: 32624210
Cell death is a finely regulated process occurring through different pathways. Regulated cell death, either through apoptosis or regulated necrosis offers the possibility of therapeutic intervention. Necroptosis and ferroptosis are...
6.
Guerrero-Hue M, Farre-Alins V, Palomino-Antolin A, Parada E, Rubio-Navarro A, Egido J, et al.
Curr Med Chem
. 2017 May;
24(33):3583-3605.
PMID: 28494744
Background: Renal disease is a serious health problem, with increasing incidence and prevalence. Oxidative stress and inflammation play a key role in the pathogenesis and progression of renal disease. Therefore,...
7.
Ortiz A, Sanchez-Nino M, Izquierdo M, Martin-Cleary C, Garcia-Bermejo L, Moreno J, et al.
Eur J Pharmacol
. 2015 Mar;
759:205-20.
PMID: 25814248
Acute kidney injury (AKI) and chronic kidney disease (CKD) are associated with decreased renal function and increased mortality risk, while the therapeutic armamentarium is unsatisfactory. The availability of adequate animal...
8.
Sevillano A, Cabrera J, Gutierrez E, Morales E, Merida E, Huerta A, et al.
Nefrologia
. 2015 Jan;
35(1):42-9.
PMID: 25611832
Introduction: Malignant hypertension (MHT) is an uncommon clinical manifestation of IgA Nephropathy (IgAN). Its prevalence, pathogenesis and evolution are not well known. Material And Methods: We performed a descriptive and...
9.
Sastre C, Fernandez-Laso V, Madrigal-Matute J, Munoz-Garcia B, Moreno J, Pastor-Vargas C, et al.
J Cell Mol Med
. 2014 Feb;
18(4):721-34.
PMID: 24479820
Clinical complications associated with atherosclerotic plaques arise from luminal obstruction due to plaque growth or destabilization leading to rupture. Tumour necrosis factor ligand superfamily member 12 (TNFSF12) also known as...
10.
Gutierrez E, Moreno J, Praga M
Nefrologia
. 2014 Jan;
34(1):110-4.
PMID: 24463867
The level of proteinuria continues to be the clinical parameter that is best related to the development of long-term renal failure in glomerular pathologies. This quantity is particularly important when...